Avaleht › Haavandiline koliit › Missouri
Haavandiline koliit kliinilised uuringud osariigis Missouri
16 uuringut haiguse Haavandiline koliit jaoks otsivad osalejaid osariigis Missouri.
Linnad osariigis Missouri
Ametlik uuringutekst (inglise keeles)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- BVL Research - Kansas ( Site 0292), Liberty
VärbamineFaas 3
Kõik vanused · Kõik sood · Uuendatud 2. okt 2026 · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Specialists In Gastroenterology /ID# 283939, St Louis
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- SSM Health Medical Group, Bridgeton
- GI Associates Research, LLC, Columbia
- Mid America Gastro Intestinal Consultants, Kansas City
- ja veel 1
VärbamineFaas 4
Vanused 18–80 · Kõik sood · Uuendatud 30. sept 2026 · NCT06581328A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-006, St Louis
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 29. sept 2026 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- BVL Research - Kansas ( Site 1054), Liberty
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 28. sept 2026 · NCT07463183A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Washington University, St Louis
VärbamineFaas 2/3
Vanused 2–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Washington University School of Medicine, St Louis
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- University Health Truman Medical Center, Kansas City
- ja veel 6
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. sept 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- KAD Clinical Research, St Louis
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Washington University School of Medicine, St Louis
VärbamineFaas 3
Vanused 2–19 · Kõik sood · Uuendatud 22. sept 2026 · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- KAD Clinical Research, St Louis
- Specialists in Gastroenterology, St Louis
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Mid-America Gastro-Intestinal Consultants, Kansas City
- BVL Clinical Research, Liberty
- Washington University School of Medicine, St Louis
VärbamineFaas 4
Vanused 18–65 · Kõik sood · Uuendatud 21. sept 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gateway Gastroenterology - Site Number: 8400097, Chesterfield
- BVL Clinical Research - Site Number: 8400005, Liberty
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 15. sept 2026 · NCT07185009An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gateway Gastroenterology - Site Number: 8400097, Chesterfield
- BVL Clinical Research - Site Number: 8400005, Liberty
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 20. aug 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- Gateway GI Research (Objective Health), St Louis
Värbamine
Vanused 18–85 · Kõik sood · Uuendatud 6. aug 2026 · NCT06571669A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bridgeton
- Mirador Therapeutics Selected Site, Kansas City
- Mirador Therapeutics Selected Site, Liberty
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 12. märts 2026 · NCT07113522Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.